All News #Library
Biotech
Swiss biotech Veraxa to list on Nasdaq in $1.64 billion SPAC deal
23 Apr 2025 //
REUTERS
Xlife Sciences AG Announces Veraxa Biotech NASDAQ Listing Plans
16 Dec 2024 //
PHARMAWEB

Market Place
Sourcing Support